Related references
Note: Only part of the references are listed.Incidental Receipt of Cardiac Medications and Survival Outcomes Among Patients With Stage III Non-Small-Cell Lung Cancer After Definitive Radiotherapy
Hongmei Wang et al.
CLINICAL LUNG CANCER (2015)
Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo
Soraya Mezouar et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
Kimmie Ng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Aspirin reduces lung cancer metastasis to regional lymph nodes
Fumihiro Ogawa et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Low-dose aspirin use and cancer characteristics: a population-based cohort study
F. Jonsson et al.
BRITISH JOURNAL OF CANCER (2013)
Threats to Validity of Nonrandomized Studies of Postdiagnosis Exposures on Cancer Recurrence and Survival
Jessica Chubak et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Cancer recording and mortality in the General Practice Research Database and linked cancer registries
Rachael Boggon et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
Farhat V. N. Din et al.
GASTROENTEROLOGY (2012)
Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
Kevin S. Choe et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prediagnostic Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Survival in the VITAL Study
Theodore M. Brasky et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Xiaoyun Liao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
R. E. Langley et al.
BRITISH JOURNAL OF CANCER (2011)
The platelet contribution to cancer progression
N. M. Bambace et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Contribution of platelets to tumour metastasis
Laurie J. Gay et al.
NATURE REVIEWS CANCER (2011)
Adaptation and validation of the Charlson Index for Read/OXMIS coded databases
Nada F. Khan et al.
BMC FAMILY PRACTICE (2010)
Aspirin and non-small cell lung cancer resections: effect on long-term survival
Eustace Fontaine et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Measuring cancer survival in populations: relative survival vs cancer-specific survival
Diana Sarfati et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies
Enrique F. Schisterman et al.
EPIDEMIOLOGY (2009)
Aspirin, salicylates, and cancer
Peter C. Elwood et al.
LANCET (2009)
Chronic statin therapy and the risk of colorectal cancer
Yu-Xiao Yano et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Using prescription claims data for drugs available over-the-counter (OTC)
Marianne Ulcickas Yood et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Immortal time bias in observational studies of drug effects
Samy Suissa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Application of lag-time into exposure definitions to control for protopathic bias
H. Tamim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism
Gillian M. Borthwick et al.
FASEB JOURNAL (2006)
Share Paper
